Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurrent GBM associated with survival of less than 10 months. Immunotherapies, which mobilize the… Read More
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system… Read More
[Oct. 12, 2023: Staff Writer, The Brighter Side of News] Photo of U. of I. researchers. Illinois professor of veterinary clinical medicine Dr. Timothy Fan, left, and chemistry professor Pau… Read More
Peter Lucas Neurosurgeon says the human brain, with its intricate network of billions of neurons, is one of the most complex and vital organs in the body. Unfortunately, like any other part… Read More
CNS Pharmaceuticals (NASDAQ: CNSP) recently announced rapid enrollment in its potentially pivotal study involving its flagship drug candidate, Berubicin, and is moving closer to reporting th… Read More
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system… Read More
Image Source: www.psychreg.org
New Study Reveals Insights into Difficult-to-Treat Neuroendocrine Tumors
Neoadjuvant Immune Checkpoint Blockade Shows Promise in Cancer Treatment
In a groundb… Read More
CNS Pharmaceuticals is conducting a global clinical trial to evaluate its flagship drug candidate for treating glioblastoma, a deadly brain cancer
CNS has enrolled 200 of its planne… Read More
The therapeutic areas of clinical research guide researchers, physicians, and biopharma companies in pursuing improved healthcare interventions and patient outcomes. The most common therapeu… Read More
Researchers at UTSA are looking into Sweet Annie, a plant that has been used in traditional Chinese medicine for at least 2,000 years. They are interested in the plant’s possible medic… Read More
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system… Read More
This article is reviewed by an expert
Baheda, also known as Terminalia bellirica, is a remarkable tree from the family Combretaceae. Renowned as Bibhitaki, Vibhitaki, or Baheda in India… Read More
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous syst… Read More
With the pandemic acting as an accelerant, the healthcare industry is embracing AI enthusiastically. According to a 2020 survey by Optum, 80% of healthcare organizations have an AI strategy… Read More
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system… Read More
The combination of oncolytic DNX-2401 virotherapy with pembrolizumab (Keytruda) failed to meet a phase I/II study’s primary endpoint of objective response rate (ORR) in patients with… Read More
Introduction to HER and ADCs
Members of the human epidermal growth factor receptor (HER) family, including HER1 (EGFR), HER2, HER3, and HER4, play a core role in regulating cell prolifera… Read More
Uses of Mebendazole
Mebendazole is a broad-spectrum anthelmintic medication that is primarily used for the treatment of various parasitic infections. Here are the main uses of Mebendazole:
A… Read More
– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments –… Read More
“Orphan” drug status is offering these ASX pharma stocks a chance to turn a healthy profit – and give hope to those suffering rare conditions.
Rare or “orphan&rd… Read More
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system… Read More
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system… Read More